Germany’s Merck in fresh investment to make bioreactor gear in France

The new site, which will see the creation of 350 jobs, will be Merck’s first such facility in Europe and will likely come on stream at the end of this year, the diversified group said in a statement on Wednesday.

“Our new European production line will increase global capacity for urgently needed supplies of single-use products to makers of vaccines and therapeutics,” Merck said in a statement.

Merck, which competes in lab equipment with Thermo Fisher and Sartorius, also has a site for single-use plastic bags for bioreactors in Wuxi, China.

The single-use bioreactors market has seen double-digit percentage growth because the technology makes biotech production more flexible, cheaper and faster, Merck said, adding that the coronavirus pandemic has even increased that pace.